首页> 美国卫生研究院文献>Open Forum Infectious Diseases >264Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United States

【2h】

264Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United States

机译：264 Tedizolid活性和抗药性（STAR）计划的监测结果：2013年从美国收集的革兰氏阳性临床分离株的体外药敏性

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

期刊名称 Open Forum Infectious Diseases
作者
Paul Bien; Philippe Prokocimer;
展开▼
作者单位

展开▼
年(卷),期 2014(1),Suppl 1
年度 2014
页码 S112
总页数 1
原文格式 PDF
正文语种
中图分类病毒传染病;
关键词

相似文献

外文文献
中文文献
专利

1. Results of the Surveillance of Tedizolid Activity and Resistance Program: in vitro susceptibility of Gram-positive pathogens collected in 2011 and 2012 from the United States and Europe [J] . Sahm Daniel F., Deane Jennifer, Bien Paul A., Diagnostic microbiology and infectious disease . 2015,第2期

机译：噻虫啉活性和抗药性计划的监测结果：2011年和2012年从美国和欧洲收集的革兰氏阳性病原体的体外敏感性
2. In vitro activity of tigecycline against 3989 Gram-negative and Gram-positive clinical isolates from the United States Tigecycline Evaluation and Surveillance Trial (TEST Program; 2004). [J] . Bouchillon SK, Hoban DJ, Johnson BM, Diagnostic microbiology and infectious disease . 2005,第3期

机译：来自美国Tigecycline评估和监视试验（TEST计划; 2004年）的替加环素对3989株革兰氏阴性和革兰氏阳性临床分离株的体外活性。
3. Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015) [J] . Pfaller Michael A., Mendes Rodrigo E., Streit Jennifer M., Antimicrobial agents and chemotherapy. . 2017,第7期

机译：从领导监督计划（2011年到2015年）中美国对美国临床重要革兰氏阳性Cocci进行临床上重要革兰氏阳性Coccc的五年综述
4. In Vitro Activity Of Six Antimicrobial Agents Against Ten Lawsonia Intracellularis Isolates From The United States And Europe [C] . S. Wattanaphansak, D. Dau, R. Singer, Proceedings of the 3rd Congress of the Asian Pig Veterinary Society . 2007

机译：六种抗微生物剂针对来自美国和欧洲的十种胞内劳森菌的体外活性
5. Five-Year Summary of In Vitro Activity and Resistance Mechanisms of Linezolid against Clinically Important Gram-Positive Cocci in the United States from the LEADER Surveillance Program (2011 to 2015) [O] . Michael A. Pfaller, Rodrigo E. Mendes, Jennifer M. Streit, 2017

机译：从LEADER监测计划（2011年至2015年）对美国利奈唑胺对临床上重要的革兰氏阳性球菌的体外活性和耐药机制的五年总结
6. Surveillance of tedizolid activity and resistance: In vitro susceptibility of Gram-positive pathogens collected over 5 years from the United States and Europe [O] . Bensaci Mekki, Sahm Daniel 2017

机译：泰地唑活性和耐药性的监测：五年来从美国和欧洲收集的革兰氏阳性病原体的体外敏感性

264Results of the Surveillance of Tedizolid Activity and Resistance (STAR) Program: In Vitro Susceptibility of Gram-Positive Clinical Isolates Collected in 2013 From the United States

著录项

相似文献

相关主题

期刊订阅